Similarly, other natural compounds, such as geniposide [26] and catalpol [27], have also demonstrated GLP-1 receptor activation, with geniposide further showing cardioprotective effects by reducing cardiac hypertrophy via the AMPK signaling pathway [19]. The gene discussed is GLP1R; the disease is cardiac hypertrophy.